Skip to main content
View all posts

Pharmaceutical data integrity: from chromatography PDFs to LIMS

Chromatography data is high-volume, complex-format, and tied to critical quality attributes — historically a high-risk item in GMP inspections. This article maps the path from PDF to LIMS while preserving data integrity at every step.

by ChromaParse Team Reviewed by Senior QA Consultant 4 min read
GMP data integrity ALCOA+ 21 CFR Part 11 NMPA LIMS

Pharmaceutical data integrity is a focus of GMP inspections, and chromatography data — high-volume, complex format, tied to critical quality attributes — has been a high-risk item for years.

This article approaches the problem from the compliance angle: how to migrate chromatography data from PDF to LIMS while preserving data integrity end-to-end.

1. Regulatory background

1.1 FDA 21 CFR Part 11

Part 11 sets explicit requirements for electronic records and signatures:

  • Audit trail — every change must be traceable
  • Access control — only authorized personnel may create, modify, or delete electronic records
  • Tamper resistance — electronic records must be protected against tampering

1.2 WHO ALCOA+ principles

The ALCOA+ framework from WHO Technical Reports is the bedrock of data integrity:

LetterMeaningRequirement
AAttributableEach record is tied to a specific person
LLegibleRecords are readable and durable
CContemporaneousRecorded at the time of activity
OOriginalOriginal record (or verified copy) is preserved
AAccurateRecords are correct
+Complete / Consistent / Enduring / AvailableRound out ALCOA

1.3 China NMPA “Drug Records and Data Management Requirements” (2024)

Chinese regulators require truthful, accurate, complete, and traceable data management. Notably, manually transcribed data requires two-person review — which underscores the value of automation.

2. Risks across the chromatography data flow

The data passes through multiple stages from creation to archive. The manual entry from PDF to Excel is the highest-risk step:

Chromatograph → Workstation → PDF report → Manual entry to Excel → LIMS import

                                       Risk: typos, omissions, no traceability

3. Risk assessment — three approaches

3.1 Manual entry

Risk dimensionRatingNotes
Accuracy⚠️ HighHuman eye + keystroke; errors are inevitable
Completeness⚠️ MediumMulti-page tables get rows missed
Traceability❌ Very highCannot prove “this Excel cell came from that PDF cell”
Audit trail❌ NoneEntry process is undocumented

Manual entry is the worst option in a GMP environment — yet it’s the most common in practice.

3.2 Generic OCR

Risk dimensionRatingNotes
Accuracy⚠️ MediumDecimals and scientific notation often misread
Completeness⚠️ MediumCross-page tables may lose rows
Traceability⚠️ LowNo precise linkage to PDF source position
Audit trail❌ NoneNo structured audit of the extraction

3.3 ChromaParse (purpose-built)

Risk dimensionRatingNotes
Accuracy✅ LowTuned for chromatography tables, 99.9%+ accuracy
Completeness✅ LowHandles cross-page and merged-cell layouts
Traceability✅ LowSource-trace: click an Excel value → highlight in PDF
Audit trail✅ YesExtraction process is logged; mapping is verifiable

4. Best practices from PDF to LIMS

  1. Step 1 — Preserve the original. Whatever extraction method you pick, keep the original PDF. ALCOA+ “Original” requires it.

  2. Step 2 — Extract with a validated tool. Use a validated tool to produce structured data from the PDF, with values matching the PDF and source-trace available.

  3. Step 3 — Verify a sample. Spot-check 5–10% of records against the PDF source, focusing on retention times and peak areas.

  4. Step 4 — Load into LIMS. Import the validated data as Excel/CSV, ensuring format and field mapping are correct.

  5. Step 5 — Establish an audit chain. Complete chain: PDF → ChromaParse extraction → Excel intermediate → LIMS record. Every link traceable, every step verifiable.

5. Implementation tips

  1. Phased rollout — pilot with non-GMP-critical data first; expand to GMP data after accuracy is validated
  2. SOPs — write standard operating procedures for extraction, verification, and import
  3. Training — ensure operators understand both data integrity requirements and the tool
  4. Periodic review — sample-check extracted results even after the tool is in use
  5. Recordkeeping — retain extraction and verification records per GMP retention rules

Don’t just evaluate the tool — evaluate the whole data flow’s compliance. Purpose-built chromatography extraction tools (like ChromaParse) have clear advantages in accuracy, completeness, and traceability. Combined with proper validation and SOPs, they hit the best balance between GMP compliance and efficiency.


References